Jones, Anya C.
Leffler, Jonatan
Laing, Ingrid A.
Bizzintino, Joelene
Khoo, Siew-Kim
LeSouef, Peter N.
Sly, Peter D.
Holt, Patrick G.
Strickland, Deborah H.
Bosco, Anthony
Article History
Received: 2 December 2022
Accepted: 14 June 2023
First Online: 12 July 2023
Declarations
:
: This study and protocol were approved by the Child and Adolescent Health Service Human Research Ethics Committee (CAHS HECS, Approval no: RGS 2369) at Perth Children’s Hospital with written informed consent from at least one parent or guardian. Parents/guardians gave written informed consent in accordance with the Declaration of Helsinki.
: Not Applicable.
: AB is a co-inventor on a patent application that is related to this work. AB is a co-founder, equity holder, and director of the startup company Respiradigm Pty Ltd and subsidiary First Breath Health Pty Ltd that is related to this work. AB is the founder of the startup company INSiGENe Pty Ltd that is unrelated to this work. All remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.